TP53 and lung carcinoma: In this study, we used the Lewis lung cancer model, H&E staining, ELISA, immunohistochemistry and other techniques to investigate the development of lung cancer, tumor cell proliferation, immune organ index, inflammatory factor level, Ki67 and p53 and tight junction protein expression, to evaluate the efficacy of ZSP in the prevention and treatment of lung cancer.